Table of Contents 1 Market Overview 1.1 Neurological Biomarkers Introduction 1.2 Market Analysis by Type 1.2.1 Proteomics 1.2.2 Genomics 1.2.3 Imaging 1.2.4 Bioinformatics 1.2.5 Others 1.3 Market Analysis by Applications 1.3.1 Diagnostics 1.3.2 Drug Discovery 1.3.3 Personalized Medicine 1.3.4 Others 1.4 Market Analysis by Regions 1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey) 1.4.1.1 Germany Market States and Outlook (2012-2022) 1.4.1.2 France Market States and Outlook (2012-2022) 1.4.1.3 UK Market States and Outlook (2012-2022) 1.4.1.4 Italy Market States and Outlook (2012-2022) 1.4.1.5 Russia Market States and Outlook (2012-2022) 1.4.1.6 Turkey Market States and Outlook (2012-2022) 1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran) 1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022) 1.4.2.2 UAE Market States and Outlook (2012-2022) 1.4.2.3 Israel Market States and Outlook (2012-2022) 1.4.2.4 Iran Market States and Outlook (2012-2022) 1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria) 1.4.3.1 South Africa Market States and Outlook (2012-2022) 1.4.3.2 Nigeria Market States and Outlook (2012-2022) 1.4.3.3 Egypt Market States and Outlook (2012-2022) 1.4.3.4 Algeria Market States and Outlook (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Thermo Fisher 2.1.1 Business Overview 2.1.2 Neurological Biomarkers Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Merck 2.2.1 Business Overview 2.2.2 Neurological Biomarkers Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Bio-Rad Laboratories 2.3.1 Business Overview 2.3.2 Neurological Biomarkers Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Roche 2.4.1 Business Overview 2.4.2 Neurological Biomarkers Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 QIAGEN 2.5.1 Business Overview 2.5.2 Neurological Biomarkers Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Athena Diagnostics 2.6.1 Business Overview 2.6.2 Neurological Biomarkers Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Myriad RBM 2.7.1 Business Overview 2.7.2 Neurological Biomarkers Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Cisbio Bioassays 2.8.1 Business Overview 2.8.2 Neurological Biomarkers Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Wuxi APP 2.9.1 Business Overview 2.9.2 Neurological Biomarkers Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 BGI 2.10.1 Business Overview 2.10.2 Neurological Biomarkers Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Aepodia 2.11.1 Business Overview 2.11.2 Neurological Biomarkers Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Genewiz 2.12.1 Business Overview 2.12.2 Neurological Biomarkers Type and Applications 2.12.2.1 Type 1 2.12.2.2 Type 2 2.12.3 Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Proteome Sciences 2.13.1 Business Overview 2.13.2 Neurological Biomarkers Type and Applications 2.13.2.1 Type 1 2.13.2.2 Type 2 2.13.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 EMEA Neurological Biomarkers Market Competition, by Manufacturer 3.1 EMEA Neurological Biomarkers Sales and Market Share by Manufacturer 3.2 EMEA Neurological Biomarkers Revenue and Market Share by Manufacturer 3.3 EMEA Neurological Biomarkers Price by Manufacturer (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Neurological Biomarkers Manufacturer Market Share 3.4.2 Top 5 Neurological Biomarkers Manufacturer Market Share 3.5 Market Competition Trend 4 EMEA Neurological Biomarkers Market Analysis by Regions 4.1 EMEA Neurological Biomarkers Sales, Revenue and Market Share by Regions 4.1.1 EMEA Neurological Biomarkers Sales by Regions (2012-2017) 4.1.2 EMEA Neurological Biomarkers Revenue by Regions (2012-2017) 4.2 Europe Neurological Biomarkers Sales and Growth (2012-2017) 4.3 Middle East Neurological Biomarkers Sales and Growth (2012-2017) 4.4 Africa Neurological Biomarkers Sales and Growth (2012-2017) 5 Europe Neurological Biomarkers by Countries, Type, Application and Manufacturers 5.1 Europe Neurological Biomarkers Sales, Revenue and Market Share by Countries 5.1.1 Europe Neurological Biomarkers Sales by Countries (2012-2017) 5.1.2 Europe Neurological Biomarkers Revenue by Countries (2012-2017) 5.1.3 Germany Neurological Biomarkers Sales and Growth (2012-2017) 5.1.4 France Neurological Biomarkers Sales and Growth (2012-2017) 5.1.5 UK Neurological Biomarkers Sales and Growth (2012-2017) 5.1.6 Russia Neurological Biomarkers Sales and Growth (2012-2017) 5.1.7 Italy Neurological Biomarkers Sales and Growth (2012-2017) 5.1.8 Turkey Neurological Biomarkers Sales and Growth (2012-2017) 5.2 Europe Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017) 5.2.1 Europe Neurological Biomarkers Sales by Manufacturers (2016-2017) 5.2.2 Europe Neurological Biomarkers Revenue by Manufacturers (2016-2017) 5.3 Europe Neurological Biomarkers Sales by Type (2012-2017) 5.4 Europe Neurological Biomarkers Sales by Application (2012-2017) 6 Middle East Neurological Biomarkers by Countries, Type, Application and Manufacturers 6.1 Middle East Neurological Biomarkers Sales, Revenue and Market Share by Countries 6.1.1 Middle East Neurological Biomarkers Sales by Countries (2012-2017) 6.1.2 Middle East Neurological Biomarkers Revenue by Countries (2012-2017) 6.1.3 Saudi Arabia Neurological Biomarkers Sales and Growth (2012-2017) 6.1.4 Israel Neurological Biomarkers Sales and Growth (2012-2017) 6.1.5 UAE Neurological Biomarkers Sales and Growth (2012-2017) 6.1.6 Iran Neurological Biomarkers Sales and Growth (2012-2017) 6.2 Middle East Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017) 6.2.1 Middle East Neurological Biomarkers Sales by Manufacturers (2016-2017) 6.2.2 Middle East Neurological Biomarkers Revenue by Manufacturers (2016-2017) 6.3 Middle East Neurological Biomarkers Sales by Type (2012-2017) 6.4 Middle East Neurological Biomarkers Sales by Application (2012-2017) 7 Africa Neurological Biomarkers by Countries, Type, Application and Manufacturers 7.1 Africa Neurological Biomarkers Sales, Revenue and Market Share by Countries 7.1.1 Africa Neurological Biomarkers Sales by Countries (2012-2017) 7.1.2 Africa Neurological Biomarkers Revenue by Countries (2012-2017) 7.1.3 South Africa Neurological Biomarkers Sales and Growth (2012-2017) 7.1.4 Nigeria Neurological Biomarkers Sales and Growth (2012-2017) 7.1.5 Egypt Neurological Biomarkers Sales and Growth (2012-2017) 7.1.6 Algeria Neurological Biomarkers Sales and Growth (2012-2017) 7.2 Middle East Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017) 7.2.1 Middle East Neurological Biomarkers Sales by Manufacturers (2016-2017) 7.2.2 Middle East Neurological Biomarkers Revenue by Manufacturers (2016-2017) 7.3 Middle East Neurological Biomarkers Sales by Type (2012-2017) 7.4 Middle East Neurological Biomarkers Sales by Application (2012-2017) 8 EMEA Neurological Biomarkers Market Segment by Type 8.1 EMEA Neurological Biomarkers Sales, Revenue and Market Share by Type (2012-2017) 8.1.1 EMEA Neurological Biomarkers Sales and Market Share by Type (2012-2017) 8.1.2 EMEA Neurological Biomarkers Revenue and Market Share by Type (2012-2017) 8.2 Proteomics Sales Growth and Price 10.2.1 EMEA Proteomics Sales Growth (2012-2017) 10.2.2 EMEA Proteomics Price (2012-2017) 8.3 Genomics Sales Growth and Price 10.3.1 EMEA Genomics Sales Growth (2012-2017) 10.3.2 EMEA Genomics Price (2012-2017) 8.4 Imaging Sales Growth and Price 10.4.1 EMEA Imaging Sales Growth (2012-2017) 10.4.2 EMEA Imaging Price (2012-2017) 8.5 Bioinformatics Sales Growth and Price 10.5.1 EMEA Bioinformatics Sales Growth (2012-2017) 10.5.2 EMEA Bioinformatics Price (2012-2017) 8.6 Others Sales Growth and Price 10.6.1 EMEA Others Sales Growth (2012-2017) 10.6.2 EMEA Others Price (2012-2017) 9 EMEA Neurological Biomarkers Market Segment by Application 9.1 EMEA Neurological Biomarkers Sales Market Share by Application (2012-2017) 9.2 Diagnostics Sales Growth (2012-2017) 9.3 Drug Discovery Sales Growth (2012-2017) 9.4 Personalized Medicine Sales Growth (2012-2017) 9.5 Others Sales Growth (2012-2017) 10 EMEA Neurological Biomarkers Market Forecast (2017-2022) 10.1 EMEA Neurological Biomarkers Sales, Revenue and Growth Rate (2017-2022) 10.2 Neurological Biomarkers Market Forecast by Regions (2017-2022) 10.2.1 Europe Neurological Biomarkers Market Forecast by Regions (2017-2022) 10.2.1.1 Germany Neurological Biomarkers Sales Forecast 2017-2022 10.2.1.2 France Neurological Biomarkers Sales Forecast 2017-2022 10.2.1.3 UK Neurological Biomarkers Sales Forecast 2017-2022 10.2.1.4 Russia Neurological Biomarkers Sales Forecast 2017-2022 10.2.1.5 Italy Neurological Biomarkers Sales Forecast 2017-2022 10.2.1.6 Turkey Neurological Biomarkers Sales Forecast 2017-2022 10.2.2 Middle East Market Forecast by Regions (2017-2022) 10.2.2.1 Saudi Arabia Neurological Biomarkers Sales Forecast 2017-2022 10.2.2.2 Israel Neurological Biomarkers Sales Forecast 2017-2022 10.2.2.3 UAE Neurological Biomarkers Sales Forecast 2017-2022 10.2.2.4 Iran Neurological Biomarkers Sales Forecast 2017-2022 10.2.3 Africa Market Forecast by Regions (2017-2022) 10.2.3.1 South Africa Neurological Biomarkers Sales Forecast 2017-2022 10.2.3.2 Nigeria Neurological Biomarkers Sales Forecast 2017-2022 10.2.3.3 Egypt Neurological Biomarkers Sales Forecast 2017-2022 10.2.3.4 Algeria Neurological Biomarkers Sales Forecast 2017-2022 10.3 Neurological Biomarkers Market Forecast by Type (2017-2022) 10.4 Neurological Biomarkers Market Forecast by Application (2017-2022) 11 Sales Channel, Distributors, Traders and Dealers 11.1 Sales Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Future Trend 11.2 Distributors, Traders and Dealers 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology 13.2 Analyst Introduction 13.3 Data Source

List of Tables and Figures Figure Neurological Biomarkers Picture Table Product Specifications of Neurological Biomarkers Figure EMEA Sales Market Share of Neurological Biomarkers by Types in 2016 Table Neurological Biomarkers Types for Major Manufacturers Figure Proteomics Picture Figure Genomics Picture Figure Imaging Picture Figure Bioinformatics Picture Figure Others Picture Table Neurological Biomarkers Sales Market Share by Applications in 2016 Figure Diagnostics Picture Figure Drug Discovery Picture Figure Personalized Medicine Picture Figure Others Picture Figure Germany Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure France Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure UK Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure Italy Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure Russia Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure Turkey Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure Saudi Arabia Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure UAE Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure Israel Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure Iran Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure South Africa Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure Nigeria Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure Egypt Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Figure Algeria Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022) Table Thermo Fisher Basic Information, Manufacturing Base and Competitors Table Thermo Fisher Neurological Biomarkers Type and Applications Table Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck Neurological Biomarkers Type and Applications Table Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors Table Bio-Rad Laboratories Neurological Biomarkers Type and Applications Table Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Neurological Biomarkers Type and Applications Table Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table QIAGEN Basic Information, Manufacturing Base and Competitors Table QIAGEN Neurological Biomarkers Type and Applications Table QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Athena Diagnostics Basic Information, Manufacturing Base and Competitors Table Athena Diagnostics Neurological Biomarkers Type and Applications Table Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Myriad RBM Basic Information, Manufacturing Base and Competitors Table Myriad RBM Neurological Biomarkers Type and Applications Table Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Cisbio Bioassays Basic Information, Manufacturing Base and Competitors Table Cisbio Bioassays Neurological Biomarkers Type and Applications Table Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Wuxi APP Basic Information, Manufacturing Base and Competitors Table Wuxi APP Neurological Biomarkers Type and Applications Table Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table BGI Basic Information, Manufacturing Base and Competitors Table BGI Neurological Biomarkers Type and Applications Table BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Aepodia Basic Information, Manufacturing Base and Competitors Table Aepodia Neurological Biomarkers Type and Applications Table Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Genewiz Basic Information, Manufacturing Base and Competitors Table Genewiz Neurological Biomarkers Type and Applications Table Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Proteome Sciences Basic Information, Manufacturing Base and Competitors Table Proteome Sciences Neurological Biomarkers Type and Applications Table Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table EMEA Neurological Biomarkers Sales by Manufacturer (2016-2017) Figure EMEA Neurological Biomarkers Sales Market Share by Manufacturer in 2016 Figure EMEA Neurological Biomarkers Sales Market Share by Manufacturer in 2017 Table EMEA Neurological Biomarkers Revenue by Manufacturer (2016-2017) Figure EMEA Neurological Biomarkers Revenue Market Share by Manufacturer in 2016 Figure EMEA Neurological Biomarkers Revenue Market Share by Manufacturer in 2017 Table EMEA Neurological Biomarkers Price by Manufacturer (2016-2017) Figure EMEA Neurological Biomarkers Sales and Growth (2012-2017) Figure EMEA Neurological Biomarkers Revenue and Growth (2012-2017) Table EMEA Neurological Biomarkers Sales by Regions (2012-2017) Table EMEA Neurological Biomarkers Sales Market Share by Regions (2012-2017) Figure EMEA Neurological Biomarkers Sales Market Share by Regions in 2012 Figure EMEA Neurological Biomarkers Sales Market Share by Regions in 2016 Table EMEA Neurological Biomarkers Revenue by Regions (2012-2017) Table EMEA Neurological Biomarkers Revenue Market Share by Regions (2012-2017) Figure EMEA Neurological Biomarkers Revenue Market Share by Regions in 2012 Figure EMEA Neurological Biomarkers Revenue Market Share by Regions in 2016 Figure Europe Neurological Biomarkers Sales and Growth (2012-2017) Figure Middle East Neurological Biomarkers Sales and Growth (2012-2017) Figure Africa Neurological Biomarkers Sales and Growth (2012-2017) Figure Europe Neurological Biomarkers Revenue and Growth (2012-2017) Table Europe Neurological Biomarkers Sales by Countries (2012-2017) Table Europe Neurological Biomarkers Sales Market Share by Countries (2012-2017) Figure Europe Neurological Biomarkers Sales Market Share by Countries in 2012 Figure Europe Neurological Biomarkers Sales Market Share by Countries in 2016 Table Europe Neurological Biomarkers Revenue by Countries (2012-2017) Table Europe Neurological Biomarkers Revenue Market Share by Countries (2012-2017) Figure Europe Neurological Biomarkers Revenue Market Share by Countries in 2012 Figure Europe Neurological Biomarkers Revenue Market Share by Countries in 2016 Figure Germany Neurological Biomarkers Sales and Growth (2012-2017) Figure France Neurological Biomarkers Sales and Growth (2012-2017) Figure UK Neurological Biomarkers Sales and Growth (2012-2017) Figure Russia Neurological Biomarkers Sales and Growth (2012-2017) Figure Italy Neurological Biomarkers Sales and Growth (2012-2017) Figure Turkey Neurological Biomarkers Sales and Growth (2012-2017) Table Europe Neurological Biomarkers Sales by Manufacturer (2016-2017) Figure Europe Neurological Biomarkers Sales Market Share by Manufacturer in 2016 Figure Europe Neurological Biomarkers Sales Market Share by Manufacturer in 2017 Table Europe Neurological Biomarkers Revenue by Manufacturer (2016-2017) Figure Europe Neurological Biomarkers Revenue Market Share by Manufacturer in 2016 Figure Europe Neurological Biomarkers Revenue Market Share by Manufacturer in 2017 Table Europe Neurological Biomarkers Sales by Type (2012-2017) Table Europe Neurological Biomarkers Sales Share by Type (2012-2017) Table Europe Neurological Biomarkers Sales by Application (2012-2017) Table Europe Neurological Biomarkers Sales Share by Application (2012-2017) Figure Middle East Neurological Biomarkers Revenue and Growth (2012-2017) Table Middle East Neurological Biomarkers Sales by Countries (2012-2017) Table Middle East Neurological Biomarkers Sales Market Share by Countries (2012-2017) Figure Middle East Neurological Biomarkers Sales Market Share by Countries in 2012 Figure Middle East Neurological Biomarkers Sales Market Share by Countries in 2016 Table Middle East Neurological Biomarkers Revenue by Countries (2012-2017) Table Middle East Neurological Biomarkers Revenue Market Share by Countries (2012-2017) Figure Middle East Neurological Biomarkers Revenue Market Share by Countries in 2012 Figure Middle East Neurological Biomarkers Revenue Market Share by Countries in 2016 Figure Saudi Arabia Neurological Biomarkers Sales and Growth (2012-2017) Figure Israel Neurological Biomarkers Sales and Growth (2012-2017) Figure UAE Neurological Biomarkers Sales and Growth (2012-2017) Figure Iran Neurological Biomarkers Sales and Growth (2012-2017) Table Middle East Neurological Biomarkers Sales by Manufacturer (2016-2017) Figure Middle East Neurological Biomarkers Sales Market Share by Manufacturer in 2016 Figure Middle East Neurological Biomarkers Sales Market Share by Manufacturer in 2017 Table Middle East Neurological Biomarkers Revenue by Manufacturer (2016-2017) Figure Middle East Neurological Biomarkers Revenue Market Share by Manufacturer in 2016 Figure Middle East Neurological Biomarkers Revenue Market Share by Manufacturer in 2017 Table Middle East Neurological Biomarkers Sales by Type (2012-2017) Table Middle East Neurological Biomarkers Sales Share by Type (2012-2017) Table Middle East Neurological Biomarkers Sales by Application (2012-2017) Table Middle East Neurological Biomarkers Sales Share by Application (2012-2017) Figure Africa Neurological Biomarkers Revenue and Growth (2012-2017) Table Africa Neurological Biomarkers Sales by Countries (2012-2017) Table Africa Neurological Biomarkers Sales Market Share by Countries (2012-2017) Figure Africa Neurological Biomarkers Sales Market Share by Countries in 2012 Figure Africa Neurological Biomarkers Sales Market Share by Countries in 2016 Table Africa Neurological Biomarkers Revenue by Countries (2012-2017) Table Africa Neurological Biomarkers Revenue Market Share by Countries (2012-2017) Figure Africa Neurological Biomarkers Revenue Market Share by Countries in 2012 Figure Africa Neurological Biomarkers Revenue Market Share by Countries in 2016 Figure South Africa Neurological Biomarkers Sales and Growth (2012-2017) Figure Nigeria Neurological Biomarkers Sales and Growth (2012-2017) Figure Egypt Neurological Biomarkers Sales and Growth (2012-2017) Figure Algeria Neurological Biomarkers Sales and Growth (2012-2017) Table Middle East Neurological Biomarkers Sales by Manufacturer (2016-2017) Figure Middle East Neurological Biomarkers Sales Market Share by Manufacturer in 2016 Figure Middle East Neurological Biomarkers Sales Market Share by Manufacturer in 2017 Table Middle East Neurological Biomarkers Revenue by Manufacturer (2016-2017) Figure Middle East Neurological Biomarkers Revenue Market Share by Manufacturer in 2016 Figure Middle East Neurological Biomarkers Revenue Market Share by Manufacturer in 2017 Table Middle East Neurological Biomarkers Sales by Type (2012-2017) Table Middle East Neurological Biomarkers Sales Share by Type (2012-2017) Table Middle East Neurological Biomarkers Sales by Application (2012-2017) Table Middle East Neurological Biomarkers Sales Share by Application (2012-2017) Table EMEA Neurological Biomarkers Sales by Type (2012-2017) Table EMEA Neurological Biomarkers Sales Share by Type (2012-2017) Table EMEA Neurological Biomarkers Revenue by Type (2012-2017) Table EMEA Neurological Biomarkers Revenue Share by Type (2012-2017) Figure EMEA Proteomics Sales Growth (2012-2017) Figure EMEA Proteomics Price (2012-2017) Figure EMEA Genomics Sales Growth (2012-2017) Figure EMEA Genomics Price (2012-2017) Figure EMEA Imaging Sales Growth (2012-2017) Figure EMEA Imaging Price (2012-2017) Figure EMEA Bioinformatics Sales Growth (2012-2017) Figure EMEA Bioinformatics Price (2012-2017) Figure EMEA Others Sales Growth (2012-2017) Figure EMEA Others Price (2012-2017) Table EMEA Neurological Biomarkers Sales by Application (2012-2017) Table EMEA Neurological Biomarkers Sales Share by Application (2012-2017) Figure EMEA Diagnostics Sales Growth (2012-2017) Figure EMEA Drug Discovery Sales Growth (2012-2017) Figure EMEA Personalized Medicine Sales Growth (2012-2017) Figure EMEA Others Sales Growth (2012-2017) Figure EMEA Neurological Biomarkers Sales, Revenue and Growth Rate (2017-2022) Table EMEA Neurological Biomarkers Sales Forecast by Regions (2017-2022) Table EMEA Neurological Biomarkers Market Share Forecast by Regions (2017-2022) Table Europe Neurological Biomarkers Sales Forecast by Regions (2017-2022) Figure Germany Neurological Biomarkers Sales Forecast 2017-2022 Figure France Neurological Biomarkers Sales Forecast 2017-2022 Figure UK Neurological Biomarkers Sales Forecast 2017-2022 Figure Russia Neurological Biomarkers Sales Forecast 2017-2022 Figure Italy Neurological Biomarkers Sales Forecast 2017-2022 Figure Turkey Neurological Biomarkers Sales Forecast 2017-2022 Table Middle East Sales Forecast by Regions (2017-2022) Figure Saudi Arabia Neurological Biomarkers Sales Forecast 2017-2022 Figure Israel Neurological Biomarkers Sales Forecast 2017-2022 Figure UAE Neurological Biomarkers Sales Forecast 2017-2022 Figure Iran Neurological Biomarkers Sales Forecast 2017-2022 Table Africa Sales Forecast by Regions (2017-2022) Figure South Africa Neurological Biomarkers Sales Forecast 2017-2022 Figure Nigeria Neurological Biomarkers Sales Forecast 2017-2022 Figure Egypt Neurological Biomarkers Sales Forecast 2017-2022 Figure Algeria Neurological Biomarkers Sales Forecast 2017-2022 Table EMEA Neurological Biomarkers Sales Forecast by Type (2017-2022) Table EMEA Neurological Biomarkers Market Share Forecast by Type (2017-2022) Table EMEA Neurological Biomarkers Sales Forecast by Application (2017-2022) Table EMEA Neurological Biomarkers Market Share Forecast by Application (2017-2022) Table Distributors/Traders/ Dealers List